Intuitive Surgical (NASDAQ:ISRG) Stock Gets Price Target Trim from Mizuho

Intuitive Surgical (NASDAQ:ISRG) had its price target reduced by Mizuho from $415.00 to $400.00 in a research report released on Wednesday,Benzinga reports. They currently have a neutral rating on the medical equipment provider’s stock.

A number of other equities analysts have also recently issued reports on the stock. Sanford C. Bernstein reissued an “outperform” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. BTIG Research restated a “buy” rating and issued a $454.00 target price on shares of Intuitive Surgical in a research note on Wednesday. BNP Paribas Exane raised Intuitive Surgical to an “outperform” rating in a research report on Tuesday, July 28th. BMO Capital Markets reaffirmed an “outperform” rating on shares of Intuitive Surgical in a research note on Monday, July 20th. Finally, Leerink Partners dropped their price target on Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating on the stock in a research note on Friday, July 17th. Twenty-three equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $493.54.

Intuitive Surgical Stock Up 1.9%

Intuitive Surgical stock opened at $452.29 on Wednesday. The company has a market capitalization of $156.78 billion, a PE ratio of 49.76, a PEG ratio of 3.31 and a beta of 1.46. Intuitive Surgical has a 12-month low of $328.57 and a 12-month high of $603.88. The firm’s fifty day moving average is $395.50 and its 200 day moving average is $409.13.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The business had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business’s quarterly revenue was up 21.7% on a year-over-year basis. During the same period last year, the company posted $2.40 earnings per share. Sell-side analysts expect that Intuitive Surgical will post 8.87 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, VP Fredrik Widman sold 1,089 shares of the business’s stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $374.44, for a total transaction of $407,765.16. Following the transaction, the vice president directly owned 1,026 shares in the company, valued at approximately $384,175.44. The trade was a 51.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the completion of the sale, the executive vice president directly owned 5,320 shares of the company’s stock, valued at $2,016,280. The trade was a 6.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 12,370 shares of company stock valued at $4,891,989 over the last three months. Insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Bank of America Corp DE increased its position in shares of Intuitive Surgical by 3.3% during the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock valued at $1,667,388,000 after acquiring an additional 116,292 shares during the last quarter. Bank of New York Mellon Corp bought a new stake in Intuitive Surgical during the second quarter worth $1,335,753,000. Amundi lifted its holdings in Intuitive Surgical by 8.6% during the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock worth $1,119,448,000 after acquiring an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership lifted its holdings in Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after acquiring an additional 1,027,475 shares during the period. Finally, Assenagon Asset Management S.A. boosted its position in Intuitive Surgical by 13.8% in the first quarter. Assenagon Asset Management S.A. now owns 1,745,008 shares of the medical equipment provider’s stock worth $804,431,000 after purchasing an additional 211,237 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical reported third-quarter revenue of approximately $3.05 billion, up more than 20% year over year, while earnings exceeded consensus expectations. The company also highlighted continued international expansion and adoption of its robotic-surgery systems. Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
• Positive Sentiment: Several firms remain constructive: BTIG, Stifel Nicolaus, Piper Sandler, and Oppenheimer reaffirmed or maintained Buy ratings. Baird also raised its price target, while Erste Group upgraded the stock to Buy. ISRG was added to the Zacks Rank #1 Strong Buy list. New Strong Buy Stocks for October 23rd
• Neutral Sentiment: The quarter included roughly $450 million of costs tied to an antitrust settlement, along with pricing-related pressure, which reduced margins. These items appear largely nonrecurring, but investors are assessing their effect on near-term profitability. Intuitive Surgical Reports Q3 2026 Earnings Impacted by $450M Antitrust Settlement
• Negative Sentiment: The key concern is that U.S. da Vinci procedure growth slowed to its lowest level since the COVID period. Investors worry that decelerating domestic demand could make it harder for Intuitive Surgical to sustain its premium valuation, which remains above 50 times earnings. Intuitive Surgical Sinks as U.S. da Vinci Growth Slows
• Negative Sentiment: RBC lowered its expectations for ISRG, and an analyst downgrade contributed to a gap lower in the shares. The market is emphasizing forward growth and valuation rather than the headline earnings beat. Intuitive Surgical Shares Gap Down Following Analyst Downgrade

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.